Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03620110 · ClinicalTrials.gov registry record
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
A clinical trial, sponsored by Illumina.
- Completed
- Registry status
- 2,209
- Enrollment target
NCT03620110: Completed study, sponsored by Illumina.
NCT03620110 is a clinical trial that has completed, run by Illumina. The registered enrollment target is 2,209 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03620110 has completed, sponsored by Illumina.
- COMPLETED
- Registry status
- 2,209 participants
- Enrollment target
Study Summary
The purpose of this study is to collect whole blood samples from women with viable pregnancies of at least 10 weeks gestation (at any risk for fetal chromosomal anomaly) for future testing with an investigational noninvasive prenatal test(s) (NIPTs), and to establish clinical truth compared to a clinical reference standard.
Primary Outcome
Collect up to 2,200 maternal blood samples with the number of affected samples with chromosomal aneuploidy less than 0.5% based on clinical data from standard of care invasive procedure, neonate physical exam or chromosomal microarray result from the neonate buccal swab specimen.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,209 participants |
| Start Date | 2018-05-21 |
| Est. Completion | 2019-12-30 |
What the finished NCT03620110 record still lists
NCT03620110 is an observational study that tracks outcomes without assigning an intervention. Its 2,209 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03620110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03620110 about?
NCT03620110 is a clinical study titled "A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test". The purpose of this study is to collect whole blood samples from women with viable pregnancies of at least 10 weeks gestation (at any risk for fetal chromosomal anomaly) for future testing with an investigational noninvasive prenatal test(s) (NIPTs), and to establish clinical truth compared to a cli...
What is the current status of trial NCT03620110?
This trial is currently completed. The enrollment target is 2,209 participants. The study started on 2018-05-21. Estimated completion is 2019-12-30.
Who is sponsoring clinical trial NCT03620110?
This trial is sponsored by Illumina, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI